Multidrug-resistant bacterial infections of the cornea are a leading cause of blindness and cannot be effectively managed with current ophthalmic […]
FDA Approves First Drug for Neurotrophic Keratitis
THURSDAY, Aug. 23, 2018 — Oxervate (cenegermin) has been approved by the U.S. Food and Drug Administration to treat neurotrophic […]